Technology Stocks Slide But Other Sectors Hold Up Better
at Investor's Business Daily - 2 hrs 49 mins ago
A harsh sell-off in the market Thursday did not spare many stocks in Your Weekly Review. Nearly every stock on the screen closed lower, and the selling affected certain sectors more than others. However, few leaders triggered outright sell signals....
Final Glance: Biotechnology companies
AP - Thu Sep 25, 5:02PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were down at the close of trading:
Stocks Get Hit Hard; GoPro, Skechers Buck Weakness
at Investor's Business Daily - Thu Sep 25, 3:23PM CDT
Stocks suffered their biggest losses in nearly two months Thursday amid mixed data on weekly jobless claims and durable goods. Hurt by a near 4% drop in Apple (AAPL), the Nasdaq tumbled 1.9%. The S&P 500 lost 1.6%. Both indexes breached support at...
Midday Glance: Biotechnology companies
AP - Thu Sep 25, 12:24PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are down at 1 p.m.:
Early Glance: Biotechnology companies
AP - Thu Sep 25, 10:40AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 10 a.m.:
Apple Fuels Tech Sell-Off; Valeant Bucks The Trend
at Investor's Business Daily - Thu Sep 25, 10:34AM CDT
Major averages were sharply lower two hours into Thursday's session. The Nasdaq slumped 1.7% as Apple cast a pall on the tech sector. The Dow Jones industrial average and S&P 500 lost 1.2% each, and small caps took another hit as the Russell 2000...
The Best Biotech Stock for Your Growth Portfolio
Motley Fool Staff - Motley Fool - Thu Sep 25, 7:45AM CDT
For those willing to endure the inevitable price roller coaster, there's tremendous opportunity in hyper-growth biotech stocks. But you have to pick the best stocks if you're going to generate market-beating returns. So we asked each of our analysts...
'Fast Money' Recap: What Market? The Focus Remains on Apple
at The Street - Thu Sep 25, 4:00AM CDT
The trading panel discussed how low the market can go and whether biotech stocks can continue to move higher.
Jim Cramer's 'Mad Money' Recap: Why You Can't Get Too Negative in This Market
at The Street - Wed Sep 24, 7:24PM CDT
Investors always need to be prepared for when common sense returns to the market, Cramer says.
Celgene's Otezla Label Expanded to Include Plaque Psoriasis - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Sep 24, 4:30PM CDT
Celgene's (CELG) Otezla gained FDA approval for plaque psoriasis.
Watch for Celgene to Potentially Pullback After Gaining 3.32% Yesterday
Comtex SmarTrend(R) - Wed Sep 24, 3:44PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $93.88 to a high of $96.30. Yesterday, the shares gained 3.3%, which took the trading range above the 3-day high of $94.96 on volume of 5.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
After Yesterday's Rally of 3.32% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Wed Sep 24, 3:44PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $93.88 to a high of $96.30. Yesterday, the shares gained 3.3%, which took the trading range above the 3-day high of $94.96 on volume of 5.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Stocks Up In Afternoon; Hasbro Jumps On Disney Deal
at Investor's Business Daily - Wed Sep 24, 2:05PM CDT
The major averages were hitting fresh intraday highs in late afternoon trading Wednesday, spurred by dovish comments from a top Federal Reserve policymaker. The Nasdaq and the Dow Jones industrial average each added 0.9%, while the S&P 500 picked up...
Stocks Rally To Session Highs; Celgene Leads Biotech Rally
at Investor's Business Daily - Wed Sep 24, 10:49AM CDT
Major averages rallied off lows and were near session highs more than two hours into Wednesday's session. The Nasdaq led the way, up 0.6%, after touching its 50-day moving average. The Dow Jones industrial average and S&P 500 added 0.5% each. NYSE...
Jim Cramer's Mad Dash: Celgene and Morgan Stanley Still Have Upside
at The Street - Wed Sep 24, 9:58AM CDT
TheStreet's Jim Cramer says he still likes Celgene and Morgan Stanley near current levels since both stocks still have upside.
Watch for Shares of Celgene (CELG) to Approach Resistance at $94.76
Comtex SmarTrend(R) - Wed Sep 24, 8:58AM CDT
Celgene (NASDAQ:CELG) has opened bullishly above the pivot of $92.78 today and has reached the first level of resistance at $93.94. Should the shares continue to rise, the resistance pivots of $94.76 and $96.74 will be of interest.
Market Maker Surveillance Report. EBAY, JRJC, MU, AAPL, RFMD, CELG, Highest Net Buy Volume With Lowest Price Friction For Tuesday, September 23rd 2014
M2 - Wed Sep 24, 3:41AM CDT
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 4582 companies with "abnormal" market making, 1424 companies with positive Friction Factors and 3854 companies with negative Friction Factors. Here is a list of the top companies with the highest net buy volume on Tuesday and lowest price Friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. eBay Inc (NASDAQ:EBAY), China Finance Online Co Ltd (NASDAQ:JRJC), Micron Technology Inc (NASDAQ:MU), Apple Inc (NASDAQ:AAPL), RF MICRO DEVICES, INC. (NASDAQ:RFMD), Celgene Corp (NASDAQ:CELG). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
Celgene's
at Investor's Business Daily - Tue Sep 23, 5:45PM CDT
Celgene's (CELG) Otezla received FDA approval for the oral treatment of psoriasis, which causes red, scaly patches on the skin and affects 7.5 mil Americans. It's typically treated with injections, like AbbVie's (ABBV) Humira. Celgene shares rose 1%...